Defensive Dividends: Why Medtronic & Realty Income Yield 3.5%+ in Uncertain Markets
Key Takeaways
- Amid mounting recession fears and near-record index levels, an investor outlines a hold-through-any-downturn thesis for Medtronic (3.5% yield, 49-year dividend growth) and Realty Income (5.2% yield, 31-year streak).
- The strategy highlights income stability as a hedge against equity volatility.
Key Intelligence
Key Facts
- 1Medtronic has increased its dividend annually for 49 consecutive years.
- 2Medtronic's dividend yield of 3.5% is at the high end of its historical range.
- 3Medtronic reported its highest annual revenue growth in a decade.
- 4Realty Income boasts a 5.2% dividend yield and a 31-year track record of annual dividend increases.
- 5The S&P 500 remains near all-time highs with high concentration in a few tech giants, prompting defensive positioning.
Highest annual revenue growth in a decade
Analysis
- Medtronic's non-discretionary product demand
- Realty Income's long-term lease cash flows
- Multi-decade dividend growth signals resilience
- Medtronic restructuring may not fully restore margins
- Rising interest rates could pressure REIT valuations
- Third unnamed stock adds opacity to the thesis
Analysis
With the S&P 500 perched at nosebleed levels and the VIX betraying underlying anxiety, professional investors are quietly rotating into instruments that reward patience rather than prophet. The latest dispatch from Motley Fool's Reuben Gregg Brewer singles out two dividend aristocrats—Medtronic and Realty Income—as linchpins for surviving what he sees as an impending deep bear market. For finance pros, the numbers tell the story: a 49-year dividend CAGR that outpaces inflation and a 5.2% cap rate in a world of sub-4% inflation become refuge from a potential 30% drawdown.
As major stock indices hover near all-time highs and investor enthusiasm remains concentrated in a narrow group of tech giants, the specter of a prolonged bear market looms larger than it has in decades. The article '3 Stocks I'm Not Selling No Matter What the Market Does' articulates a defensive, income-oriented investment posture designed to weather such a downturn. The author, Reuben Gregg Brewer, outlines a personal conviction to hold positions in Medtronic (MDT) and Realty Income (O) through any market turbulence, highlighting their dividend reliability and essential-services business models as anchors. The piece also references a third, unnamed stock, but the core thesis rests on these two stalwarts.
For finance pros, the numbers tell the story: a 49-year dividend CAGR that outpaces inflation and a 5.2% cap rate in a world of sub-4% inflation become refuge from a potential 30% drawdown.
The macroeconomic backdrop is fraught with tension. Inflation remains sticky, recession fears resurface intermittently, and geopolitical conflicts—from Ukraine to the Middle East—inject uncertainty. The S&P 500's concentration in a handful of mega-cap tech stocks means the broader market's fortunes are increasingly tied to a few names, raising the risk of a disorderly correction. In this environment, dividend-paying stocks with durable competitive advantages and recession-resistant demand gain appeal. Medtronic, with a 49-year streak of annual dividend increases and a 3.5% yield near its historical high, operates in medical devices—a sector where demand is largely non-discretionary. The company recently reported its highest annual revenue growth in a decade, signaling that a multiyear restructuring is bearing fruit despite margin headwinds. Similarly, Realty Income, a net-lease REIT, offers a 5.2% dividend yield and a 31-year history of dividend growth. Its portfolio of single-tenant retail and industrial properties on long-term leases provides cash flow visibility that many equity sectors lack. Both firms provide income that can cushion capital losses during a bear market.
What to Watch
From a tactical perspective, holding through a downturn rather than attempting to time the market has historically proven effective for high-quality dividend growers. The analysis implicitly bets that these companies' cash flows will endure even if their stock prices decline, and that they will continue raising dividends. Medtronic's yield is attractive relative to its own history, suggesting a valuation entry point, while Realty Income's REIT structure mandates it distribute 90% of taxable income, offering a natural hedge against inflation if rents rise. Yet risks exist: Medtronic's restructuring may stall, and rising interest rates could pressure REIT valuations. However, for an investor prioritizing income and capital preservation, the strategy aligns with the adage that 'time in the market beats timing the market.'
The broader market implication is a potential rotation from growth to quality and income if economic headwinds intensify. Defensive sectors like healthcare and real estate could see relative outperformance, and dividend ETFs might attract inflows. The article's takeaway isn't just about individual stocks; it reflects a growing sentiment among prudent investors that maintaining exposure to reliable dividend payers is a form of risk management in a late-cycle economy. As the Federal Reserve's rate path remains uncertain and earnings multiples are stretched, the margin of safety in Medtronic and Realty Income lies not in price appreciation but in dividends that compound even during a selloff.
Sources
Sources
Based on 4 source articles- Reuben Gregg Brewer (us)3 Stocks I'm Not Selling No Matter What the Market DoesJun 27, 2026
- fool.com3 Stocks Im Not Selling No Matter What the Market DoesJun 27, 2026
- finance.yahoo.com3 Stocks Im Not Selling No Matter What the Market DoesJun 27, 2026
- fool.com3 Stocks Im Not Selling No Matter What the Market DoesJun 27, 2026
How we covered this story
Every story in our finance coverage is assembled from multiple primary sources, cross-referenced for factual consistency, and scored along three independent dimensions: sentiment, operational impact, and source-cluster confidence. Single-source rumors and unverifiable claims do not pass our editorial gate. When a story shows "Verified by N sources" with N≥2, the development is independently corroborated; when N=1, we mark it explicitly so readers can weigh the signal accordingly.
Impact scoring uses a 1-10 scale weighted toward regulatory, financial, and operational consequence rather than coverage volume. A topic that runs in every outlet but moves no real decisions ranks lower than a niche regulatory filing that reshapes how operators in the finance space have to behave. Read our full methodology for the scoring rubric, our glossary for term definitions, and our trends index for the longitudinal view across the beat.
| Signal on this page | What it tells you |
|---|---|
| Verified by N sources | Independent corroboration count. N≥2 is our confidence floor; N=1 is marked explicitly. |
| Impact score (1-10) | Regulatory + financial + operational weight. 8+ signals an experienced-operator action item. |
| Sentiment | Five-tier classification trained on labeled finance-specific corpora. |
| Timeline | Where applicable, the related-events sequence that contextualizes today's development. |